Back to Search
GERALD SHAPIRO, PHARMD
PHARMD
Pharmacist
NPI: 1669458204Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain).
PMID 18230015·Health Psychol·2008
2-rct
Cyclin-dependent kinase pathways as targets for cancer treatment.
PMID 16603719·J Clin Oncol·2006
6-review
Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.
PMID 15217973·Clin Cancer Res·2004
6-review
Sequence-specific targeting of two bases on both DNA strands by the somatic hypermutation mechanism.
PMID 12943801·Mol Immunol·2003
7-preclinical
Evolution of Ig DNA sequence to target specific base positions within codons for somatic hypermutation.
PMID 11859119·J Immunol·2002
7-preclinical
DNA target motifs of somatic mutagenesis in antibody genes.
PMID 12498382·Crit Rev Immunol·2002
6-review
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.
PMID 11410495·Clin Cancer Res·2001
3-trial
The physiology of p16(INK4A)-mediated G1 proliferative arrest.
PMID 11325039·Cell Biochem Biophys·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 444 S FLOWER ST, 100
LOS ANGELES, CA 90071 - Phone
- (213) 612-4300
Quick Facts
- NPI
- 1669458204
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile